Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating

Market Intelligence Analysis

AI-Powered 90% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters

Truist lowered its price target on Insulet Corporation (PODD) to $360, maintaining a Buy rating, citing strong Q4 results driven by Omnipod 5's global success.

Market Impact

Market impact analysis based on bullish sentiment with 90% confidence.

Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term
Affected Symbols

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Insulet Corporation (NASDAQ:PODD) is among the 10 High Growth S&P 500 Stocks to Buy Now. Truist on February 19, 2026, lowered its price target on Insulet Corporation (NASDAQ:PODD) to $360 from $390 and maintained a Buy rating. The firm said Insulet delivered another strong Q4 beat, supported by broad global strength in Omnipod 5 as […]

Continue Reading
Full article on Yahoo Finance
Read Full Article
AI Breakdown

Summary

Truist lowered its price target on Insulet Corporation (PODD) to $360, maintaining a Buy rating, citing strong Q4 results driven by Omnipod 5's global success.

Market Impact

Market impact analysis based on bullish sentiment with 90% confidence.

Time Horizon

Short Term

Original article published by Yahoo Finance on February 27, 2026.
Analysis and insights provided by AnalystMarkets AI.